2024 ICD-10-CM Diagnosis Code C50.81

by

Malignant neoplasm of overlapping sites of breast, female

  • C50.81 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • The 2024 edition of ICD-10-CM C50.81 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of C50.81 – other international versions of ICD-10 C50.81 may differ.

The following code(s) above C50.81 contain annotation back-references

 that may be applicable to C50.81:

  • C00-D49  Neoplasms
  • C50  Malignant neoplasm of breast

Code History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change